Edesa Biotech, Inc.
Edesa Biotech, Inc. (EDSA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
edsa · pe ratio · data through Sep 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Edesa Biotech, Inc. (EDSA) measures how much investors pay for each dollar of the company's trailing earnings. EDSA's current PE ratio of N/A is calculated by dividing its stock price of $5.37 by its TTM earnings per share of -$1.27.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-09-30
PE Ratio History
2008 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Edesa Biotech, Inc.You EDSA | $48M | N/A | — | -$1.27 |
 BioRestorative Therapies, Inc. BRTX | $3M | N/A | — | -$1.58 |
 Cocrystal Pharma, Inc. COCP | $10M | N/A | — | -$0.78 |
 Dogwood Therapeutics, Inc. DWTX | $3M | N/A | — | -$4.17 |
 Ernexa Therapeutics Inc. ERNA | $2M | N/A | — | -$55.83 |
 Evogene Ltd. EVGN | $5M | N/A | — | -$1.08 |
 Imunon, Inc. IMNN | $5M | N/A | — | -$6.83 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-09-30Latest FY2025 | — | $-1.27 | — | |
2024-09-30 FY2024 | — | $-1.93 | — | |
2023-09-30 FY2023 | — | $-2.93 | — | |
2022-09-30 FY2022 | — | $-8.37 | — | |
2021-09-30 FY2021 | — | $-7.74 | — | |
2020-09-30 FY2020 | — | $-5.18 | — | |
2019-09-30 FY2019 | — | $-4.15 | — | |
2018-09-30 FY2018 | — | $-10.54 | — | |
2017-09-30 FY2017 | — | $-218.72 | — | |
2016-09-30 FY2016 | — | $-23.92 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Edesa Biotech, Inc. (EDSA) measures how much investors pay for each dollar of the company's trailing earnings. EDSA's current PE ratio of N/A is calculated by dividing its stock price of $5.37 by its TTM earnings per share of -$1.27.
Frequently asked questions
EDSA pe ratio · 6 questionsEDSA's current PE ratio is N/A as of 2026-06-09, based on a stock price of $5.37 and TTM EPS of -$1.27. Data sourced from Financial Modeling Prep via EDSA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Edesa Biotech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09